BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.77−0.33 (-6.47%)
Close on Nov 18, 2026Market cap $218.93MP/E –Yield –
BioAge Labs revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
BioAge Labs's revenue for the twelve months ending Jun 30, 2026 was $10.36M, up 168.1% year over year. For fiscal 2025 it was $9.00M.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.00M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.45M | +1.6% |
| Q1 FY2026 | Mar 31, 2026 | $2.77M | +91.0% |
| Q4 FY2025 | Dec 31, 2025 | $3.08M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.05M | – |
| Q2 FY2025 | Jun 30, 2025 | $2.41M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.45M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
See a number that looks wrong?